Prediction of isoprene diepoxide levels in vivo in mouse, rat and man using enzyme kinetic data in vitro and physiologically-based pharmacokinetic modelling

被引:17
|
作者
Bogaards, JJP [1 ]
Freidig, AP [1 ]
van Bladeren, PJ [1 ]
机构
[1] TNO, Nutr & Food Res, Div Toxicol, NL-3700 AJ Zeist, Netherlands
关键词
isoprene; metabolism; cytochrome P450; glutathione S-transferase; epoxide hydrolase; PBPK modelling;
D O I
10.1016/S0009-2797(01)00276-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The present study was designed to explain the differences in isoprene toxicity between mouse and rat based on the liver concentrations of the assumed toxic metabolite isoprene diepoxide. In addition, extrapolation to the human situation was attempted. For this purpose, enzyme kinetic parameters K-m and V-max were determined in vitro in mouse, rat and human liver microsomes/cytosol for the cytochrome P450-mediated formation of isoprene mono- and diepoxides, epoxide hydrolase mediated hydrolysis of isoprene mono- and diepoxides, and the glutathione S-transferases mediated conjugation of isoprene monoepoxides. Subsequently, the kinetic parameters were incorporated into a physiologically-based pharmacokinetic model, and species differences regarding isoprene diepoxide levels were forecasted. Almost similar isoprene diepoxide liver and lung concentrations were predicted in mouse and rat, while predicted levels in humans were about 20-fold lower. However, when interindividual variation in enzyme activity was introduced in the human model, the levels of isoprene diepoxide changed considerably. It was forecasted that in individuals having both an extensive oxidation by cytochrome P450 and a low detoxification by epoxide hydrolase, isoprene diepoxide concentrations in the liver increased to similar concentrations as predicted for the mouse. However, the interpretation of the latter finding for human risk assessment is ambiguous since species differences between mouse and rat regarding isoprene toxicity could not be explained by the predicted isoprene diepoxide concentrations. We assume that other metabolites than isoprene diepoxide or different carcinogenic response might play a key role in determining the extent of isoprene toxicity. In order to confirm this, in vivo experiments are required in which isoprene epoxide concentrations will be established in rats and mice. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:247 / 265
页数:19
相关论文
共 50 条
  • [21] Physiologically based kinetic modelling based prediction of in vivo rat and human acetylcholinesterase (AChE) inhibition upon exposure to diazinon
    Shensheng Zhao
    Sebastiaan Wesseling
    Bert Spenkelink
    Ivonne M. C. M. Rietjens
    Archives of Toxicology, 2021, 95 : 1573 - 1593
  • [22] Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail data
    Nordmark, Anna
    Andersson, Anita
    Baranczewski, Pawel
    Wanag, Ewa
    Stahle, Lars
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (02) : 167 - 178
  • [23] Assessment of interaction potential of AZD2066 using in vitro metabolism tools, physiologically based pharmacokinetic modelling and in vivo cocktail data
    Anna Nordmark
    Anita Andersson
    Pawel Baranczewski
    Ewa Wanag
    Lars Ståhle
    European Journal of Clinical Pharmacology, 2014, 70 : 167 - 178
  • [24] Using physiologically based pharmacokinetic modelling for in silico-in vitro-in vivo extrapolation to predict chemical exposure
    Lawless, M.
    Zhou, H.
    Fraczkiewicz, G.
    TOXICOLOGY LETTERS, 2016, 258 : S119 - S120
  • [25] Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols
    Marije Strikwold
    Bert Spenkelink
    Laura H. J. de Haan
    Ruud A. Woutersen
    Ans Punt
    Ivonne M. C. M. Rietjens
    Archives of Toxicology, 2017, 91 : 2119 - 2133
  • [26] Integrating in vitro data and physiologically based kinetic (PBK) modelling to assess the in vivo potential developmental toxicity of a series of phenols
    Strikwold, Marije
    Spenkelink, Bert
    de Haan, Laura H. J.
    Woutersen, Ruud A.
    Punt, Ans
    Rietjens, Ivonne M. C. M.
    ARCHIVES OF TOXICOLOGY, 2017, 91 (05) : 2119 - 2133
  • [27] Combining in vitro embryotoxicity data with physiologically based kinetic (PBK) modelling to define in vivo dose–response curves for developmental toxicity of phenol in rat and human
    Marije Strikwold
    Bert Spenkelink
    Ruud A. Woutersen
    Ivonne M. C. M. Rietjens
    Ans Punt
    Archives of Toxicology, 2013, 87 : 1709 - 1723
  • [28] PREDICTION OF HUMAN PHARMACOKINETICS OF ORGANIC ANIONS USING PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL INCORPORATING HEPATIC UPTAKE CLEARANCE ESTIMATED FROM IN VITRO EXPERIMENTS
    Ogasawara, Akihito
    Nakamaru, Yoshinobu
    Kojima, Koki
    Shimizu, Hidetoshi
    Suzuki, Masayuki
    Kume, Toshiyuki
    DRUG METABOLISM REVIEWS, 2012, 44 : 43 - 43
  • [29] The Use of In Vitro Toxicity Data and Physiologically Based Kinetic Modeling to Predict Dose-Response Curves for In Vivo Developmental Toxicity of Glycol Ethers in Rat and Man
    Louisse, Jochem
    de Jong, Esther
    van de Sandt, Johannes J. M.
    Blaauboer, Bas J.
    Woutersen, Ruud A.
    Piersma, Aldert H.
    Rietjens, Ivonne M. C. M.
    Verwei, Miriam
    TOXICOLOGICAL SCIENCES, 2010, 118 (02) : 470 - 484
  • [30] Physiologically-Based Kinetic Modeling Predicts Similar In Vivo Relative Potency of Senecionine N-Oxide for Rat and Human at Realistic Low Exposure Levels
    Widjaja, Frances
    Alhejji, Yasser
    Yangchen, Jamyang
    Wesseling, Sebastiaan
    Rietjens, Ivonne M. C. M.
    MOLECULAR NUTRITION & FOOD RESEARCH, 2023, 67 (04)